{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:33:12Z","timestamp":1787841192815,"version":"build-2784847793"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Peritoneal surface malignancies (PSMs), such as pseudomyxoma peritonei, mesothelioma, and advanced metastases from ovarian, colorectal, gastric cancers, and sarcomatosis, are often categorized as terminal stage IV diseases. Cytoreductive surgery (CRS) combined with Hyperthermic intraperitoneal chemotherapy (HIPEC) has revolutionized outcomes, improving five-year survival rates to 50%\u201360% in selected cohorts, with up to 15% of patients achieving cure. A central component of CRS is total peritonectomy, which demands extensive exposure of the abdominal and subdiaphragmatic surfaces. However, specialized retractors designed for this purpose are currently limited to costly international systems, priced between \u20b915\u201350 lakhs, and are largely unavailable in resource-constrained regions. The RayTract\n                    <jats:sub>Ab-C<\/jats:sub>\n                    system has been developed as a cost-effective, multipurpose, self-retaining retractor specifically designed for CRS and HIPEC. The device includes a modular rail clamp, adjustable horizontal rod with arms, and six curvilinear blades engineered for pelvic, abdominal, and chest wall retraction. This configuration enables simultaneous exposure of multiple compartments, reduces reliance on surgical assistants, and facilitates safer and more efficient peritonectomy. RayTract\n                    <jats:sub>Ab-C<\/jats:sub>\n                    has demonstrated significant ergonomic and practical advantages during prototyping, with anticipated benefits in accessibility, cost reduction, and surgical independence. Further clinical evaluation is warranted to assess its role in standardizing CRS-HIPEC procedures across diverse surgical settings.\n                  <\/jats:p>","DOI":"10.4103\/jcrt.jcrt_2016_25","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:06:47Z","timestamp":1774876007000},"page":"175-177","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["RayTractAb-C: A novel multipurpose adjustable self-retaining retractor system for cytoreductive surgery and peritonectomy"],"prefix":"10.4103","volume":"22","author":[{"given":"Mukurdipi","family":"Ray","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"R1-20260331","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12957-025-03869-0","article-title":"The role of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in ovarian carcinoma: Where do we stand today?A comprehensive review and clinical insights from a leading oncology center in India","volume":"23","author":"Ray","year":"2025","journal-title":"World J Surg Oncol"},{"key":"R2-20260331","first-page":"29","article-title":"Peritonectomy procedures","volume":"2","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"R3-20260331","first-page":"987475","article-title":"Cytoreductive surgery and HIPEC for peritoneal carcinomatosis in the elderly","author":"Spiliotis","year":"2014","journal-title":"Int J Surg Oncol 2014"},{"key":"R4-20260331","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","article-title":"Society of Surgical Oncology Annual Meeting. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement. Society of Surgical Oncology","volume":"14","author":"Esquivel","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R5-20260331","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.139.1.20","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer","volume":"139","author":"Glehen","year":"2004","journal-title":"Arch Surg"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2016_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:45:26Z","timestamp":1787838326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2016_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2016_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-09-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}